# LEVETIRACETAM IN SODIUM CHLORIDE
> **ANDA207160** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2017-01-04
## Drug
- **FDA Application Number:** ANDA207160
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVETIRACETAM IN SODIUM CHLORIDE
- **Generic name:** LEVETIRACETAM IN SODIUM CHLORIDE
- **Active ingredients:** LEVETIRACETAM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** EUGIA PHARMA
- **Manufacturer:** Eugia US LLC
- **First approval:** 2017-01-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207160)
---
*AI Analytics · CC0 1.0*